Dr. Strayer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
132 S 10th St
Ste 285K
Philadelphia, PA 19107Phone+1 215-503-5642Fax+1 215-503-4817
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1976 - 1979
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1976
Certifications & Licensure
- CA State Medical License 1980 - 2026
- PA State Medical License 1992 - 2024
- TX State Medical License 1987 - 1997
- CT State Medical License 1983 - 1986
- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 42 citationsPreventing HIV-1 tat-induced neuronal apoptosis using antioxidant enzymes: Mechanistic and therapeutic implicationsLokesh Agrawal, Jean-Pierre Louboutin, David S. Strayer
Virology. 2007-07-05 - 29 citationsGene therapy for human α1-antitrypsin deficiency in an animal model using SV40-Derived vectorsYuyou Duan, Jian Wu, Jian Liang Zhu, Shu Ling Liu, Iwata Ozaki
Gastroenterology. 2004-10-01 - 34 citationsEfficient CNS gene delivery by intravenous injectionJean-Pierre Louboutin, Alena A. Chekmasova, Elena Marusich, J. Roy Chowdhury, David S. Strayer
Nature Methods. 2010-11-01
Press Mentions
- Rubins Pathology Flash Cards FirstJune 28th, 2020
Grant Support
- Targeting HIV Infection Of The CNS Using Gene DeliveryNational Institute Of Mental Health2004–2008
- Focusing Immunity VS Botulinum Toxin With Cytokine DNANational Institute Of Allergy And Infectious Diseases2003–2007
- SFV Gene Delivery To Inhibit HIV And SIV IntegraseNational Institute Of Allergy And Infectious Diseases1997–2005
- Protecting CNS Cells From HIV And Hiv-Induced InjuryNational Institute Of Mental Health2003–2004
- Sv40-Based Combination Genetic Therapies For HIV/SIVNational Institute Of Allergy And Infectious Diseases2000–2003
- Use Of SV40 Derived Vectors To Inhibit HIV 1 InfectionNational Institute Of Allergy And Infectious Diseases2000–2002
- Core--Vector FacilityNational Institute Of Allergy And Infectious Diseases2000–2002
- Animal Models Of Aids--Polytar Inhibition Of SIVNational Center For Research Resources1998–2001
- Pathogenesis Of Malignant FibromatosisNational Cancer Institute1990–2001
- Immunization Against Lentiviral GP120 Using SV40 VectorsNational Institute Of Allergy And Infectious Diseases1999–2000
- Inhibition Of Cellular SignalingNational Institute Of General Medical Sciences1997–1999
- Regulation Of P53 Expression By C7 Transcription FactorNational Institute Of General Medical Sciences1996–1999
- Gastric Tumors Induced By An Egf-Like Growth FactorNational Cancer Institute1993
- Pathogenesis Of Malignant FibromatosisNational Cancer Institute1988–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: